These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 3721420

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Magnesium pemoline and dextroamphetamine: a controlled study in children with minimal brain dysfunction.
    Conners CK, Taylor E, Meo G, Kurtz MA, Fournier M.
    Psychopharmacologia; 1972; 26(4):321-36. PubMed ID: 4508756
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Stimulant medications in adults with attention deficit disorder.
    Gauthier M.
    Can J Psychiatry; 1984 Aug; 29(5):435-40. PubMed ID: 6148139
    [Abstract] [Full Text] [Related]

  • 27. Evaluating and managing attention deficit disorder in children who are deaf or hard of hearing.
    Kelly D, Forney J, Parker-Fisher S, Jones M.
    Am Ann Deaf; 1993 Oct; 138(4):349-57. PubMed ID: 8273706
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effectiveness of attention-deficit/hyperactivity treatment and diagnosis methods tested.
    Rep Med Guidel Outcomes Res; 2000 Feb 17; 11(4):1-2, 5-7. PubMed ID: 11768409
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Social impact of stimulant treatment for hyperactive children.
    Whalen CK, Henker B.
    J Learn Disabil; 1991 Apr 17; 24(4):231-41. PubMed ID: 1875158
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Pemoline and lithium in a patient with attention deficit disorder.
    Brown RP, Ingber PS, Tross S.
    J Clin Psychiatry; 1983 Apr 17; 44(4):146-8. PubMed ID: 6403515
    [No Abstract] [Full Text] [Related]

  • 36. Pemoline, methylphenidate, and placebo in children with minimal brain dysfunction.
    Conners CK, Taylor E.
    Arch Gen Psychiatry; 1980 Aug 17; 37(8):922-30. PubMed ID: 7406656
    [Abstract] [Full Text] [Related]

  • 37. Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis with focus on bupropion.
    Stuhec M, Munda B, Svab V, Locatelli I.
    J Affect Disord; 2015 Jun 01; 178():149-59. PubMed ID: 25813457
    [Abstract] [Full Text] [Related]

  • 38. [Hyperkinetic disorders with attention deficit. Diagnostic and therapeutic approach].
    Vallée L, Pandit F.
    Pediatrie; 1991 Jun 01; 46(11):719-29. PubMed ID: 1661401
    [Abstract] [Full Text] [Related]

  • 39. Application of actigraphy in the clinical setting: use in children with attention-deficit hyperactivity disorder.
    Miller LG, Kraft IA.
    Pharmacotherapy; 1994 Jun 01; 14(2):219-23. PubMed ID: 8197043
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.